Skip to main content

Table 3 Percentage of inhibitions of COX-1 and COX-2 following treatments

From: Ardisia crispa roots inhibit cyclooxygenase and suppress angiogenesis

Concentration (μg/ml) Percentage of COX inhibition (%)
COX-1 COX-2
12.5 25 50 100 200 12.5 25 50 100 200
Aspirin 27.778 ± 0.505 36.027 ± 1.347 37.879 ± 0.842 40.067 ± 1.347 46.465 ± 0.505 33.896 ± 1.074 51.380 ± 0.154 54.294 ± 0.307 59.049 ± 0.153 62.423 ± 0.154
Celecoxib 21.212 ± 1.010 23.569 ± 1.347 27.441 ± 1.852 31.818 ± 2.189 32.492 ± 1.179 25.920 ± 0.460 48.160 ± 0.614 52.454 ± 0.614 55.675 ± 1.074 63.650 ± 0.767
ACRH 26.094 ± 0.505 32.492 ± 0.505 34.512 ± 0.169 37.037 ± 0.000 38.215 ± 0.505 25.767 ± 1.534 38.037 ± 0.920 45.399 ± 0.614 49.693 ± 1.227 56.595 ± 0.153
QRF 25.589 ± 3.367 34.848 ± 0.506 35.690 ± 0.674 36.869 ± 2.189 37.710 ± 0.674 29.908 ± 0.460 41.258 ± 0.460 49.693 ± 0.000 51.687 ± 0.460 58.129 ± 0.154
BQ 20.707 ± 0.505 21.380 ± 0.169 25.253 ± 0.337 27.273 ± 0.337 29.125 ± 0.169 27.301 ± 0.000 43.558 ± 1.688 49.233 ± 0.154 57.209 ± 0.921 61.350 ± 1.277
  1. Each concentration in its respective treatment groups were tested for its cyclooxygenase inhibitory activity (COX-1 and COX-2) in triplicate (n = 3).